Table 3.
Proteins identified in the iTRAQ assay as increased phosphorylation as effect of RA treatment (15 and 30 min)
| Name | Entry name | Accession | Ratio RA/Control | ||
|---|---|---|---|---|---|
| 15 min | 30 min | ||||
| Chromobox protein homolog 1 (HP1 β) | CBX1_HUMAN | P83916 | 1.2995 | 1.5161 | |
| Chromobox protein homolog 3 (HP1 γ) | CBX3_HUMAN | Q13185 | 1.0964 | 1.1999 | |
| Chromobox protein homolog 5 (HP1 α) | CBX5_HUMAN | P45973 | 1.3438 | ||
| hnRNP A/B | ROAA_HUMAN | Q99729 | 1.1215 | 1.3776 | |
| hnRNP A1 | ROA1_HUMAN | P09651 | 1.2672 | ||
| hnRNP A3 | ROA3_HUMAN | P51991 | 1.1674 | ||
| hnRNP D0 | HNRPD_HUMAN | Q14103 | 1.0895 | 1.3848 | |
| hnRNP G | HNRPG_HUMAN | P38159 | 1.3330 | ||
| hnRNP K | HNRPK_HUMAN | P61978 | 1.3181 | ||
| hnRNP Q | HNRPQ_HUMAN | O60506 | 1.7531 | ||
| hnRNP A2 /B11 | ROA2_HUMAN | P22626 | 0.8863 | 1.1729 | |
| HMG protein B1 (HMGB1) | HMGB1_HUMAN | P09429 | 1.6989 | 2.1734 | |
| HMG protein B2 (HMGB2) | HMGB2_HUMAN | P26583 | 1.5223 | 2.0522 | |
| HMG protein HMG-I/HMG-Y (HMGA1) | HMGA1_HUMAN | P17096 | 1.2226 | 1.2954 | |
| SF, arginine/serine-rich 1, SF2/ASF (SFRS1) | SFRS1_HUMAN | Q07955 | 1.2281 | ||
| SF, arginine/serine-rich 2, SC35 (SFSR2) | SFRS2_HUMAN | Q01130 | 1.2591 | ||
| SF, arginine/serine-rich 3, SRp20 (SFRS3) | SFRS3_HUMAN | P84103 | 1.3765 | ||
| SF, arginine/serine-rich 7, 9G8 (SFRS7) | SFRS7_HUMAN | Q16629 | 1.2293 | ||
| SF, arginine/serine-rich 9, SRp30C (SFRS9) | SFRS9_HUMAN | Q13242 | 1.1152 | 1.2155 | |
| Arsenite-resistance protein 2 (ARS2) | ARS2_HUMAN | Q9BXP5 | 1.1642 | ||
| Barrier-to-autointegration factor (BAF) | BAF_HUMAN | O75531 | 1.4720 | ||
| Complement component 1 Q | C1QBP_HUMAN | Q07021 | 1.2706 | 1.1944 | |
| Drebrin | DREB_HUMAN | Q16643 | 1.5005 | ||
| Nuclear protein Hcc-1 | HCC1_HUMAN | P82979 | 1.3270 | ||
| Nucleolin (C23) | NUCL_HUMAN | P19338 | 1.2772 | 1.3237 | |
| Nucleophosmin | NPM_HUMAN | P06748 | 1.1112 | 1.3664 | |
| HRP-3-Hepatoma-derived growth factor-related protein 3 | HDGR3_HUMAN | Q9Y3E1 | 1.1239 | 1.4624 | |
| PC4 and SFRS1-interacting protein | PSIP1_HUMAN | O75475 | 1.1608 | 1.4093 | |
| Protein DEK | DEK_HUMAN | P35659 | 1.1637 | 1.3236 | |
| Protein RED | RED_HUMAN | Q13123 | 1.2171 | 1.2655 | |
| Protein SET | SET_HUMAN | Q01105 | 1.3899 | 1.5030 | |
| RNA-binding protein 8A | RBM8A_HUMAN | Q9Y5S9 | 1.2135 | 1.3512 | |
| Scaffold attachment factor B1 (SAFB1) | SAFB1_HUMAN | Q15424 | 1.1379 | ||
| Splicing factor U2AF2 | U2AF2_HUMAN | P26368 | 1.2017 | ||
| Tropomyosin (1, 2, 3, or 4) | TPM3_HUMAN | P06753 | 1.1642 | ||
| U1 snRNP 70 kDa | RU17_HUMAN | P08621 | 1.4720 | ||
| U4/U6.U5 tri-snRNP-associated protein 1 (SART1) | SNUT1_HUMAN | O43290 | 1.2706 | 1.1944 | |
The name, the SWISS-PROT entry name and accession and the average values obtained for ratio RA/Control after 15 and 30 min RA treatment are shown. Only statistically significant values are shown.
1
hnRNP A2 /B1 is shown because it appears as decreased after 15 min and increased after 30 min RA treatment.